References
- Osoba D. The quality of life committee of the clinical trials group of the National Cancer Institute of Canada: Organization and functions. Qual Life Res 1992;1:203–11.
- Ganz PA, Bernhard J, Hurny C. Quality of life and psychosocial oncology research in Europe: State of the art. J Psychosoc Oncol 1991;9:1–22.
- Nayfield SG, Hailey BJ. Quality of life assessment in cancer clinical trials. Bethesda, MD: Division of Cancer Prevention and Control, National Cancer Institute, US. Department of Health and Human Services, 1991.
- American Cancer Society. American Cancer Society's second workshop on methodology in behavioral and psychosocial cancer research. Cancer 1991;67(suppl).
- Cella DF, Tulsky DS: Measuring quality of life today: Methodological aspects. Oncology 1990;4:29–38.
- Siegrist J, Junge A. Conceptual and methodological problems in research on the quality of life in clinical medicine. Soc Sci Med 1989;29:463–8.
- Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, . Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10:S125–S137.
- Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: Conceptual issues. Value Health 2007;10:S66–S75.
- Wagner LI, Wenzel L, Shaw E, Cella D. Patient-reported outcomes in phase II cancer clinical trials: Lessons learned and future directions. J Clin Oncol 2007;25:5058–62.
- Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. J Natl Canc Inst 2003;95:263–81.
- Blazeby JM, Kerry A, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006;24:3178–86.
- Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JPA. Reporting and interpretation of SF-36 outcomes in randomized trials: Systematic review. Br Med J 2009;338: online.
- Ware JE, Sherbourne CD. The MOS 36-item health survey (SF-36). Conceptual framework and item selection. Med Care 1992;30:473–83.
- EuroQol Group. EuroQol: A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.
- Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, . The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. J Clin Oncol 1993;11:570–9.
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, . F for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life: The EORTC QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–7.
- Melzack P. Pain measurement and assessment. New York: Raven Press; 1983.
- Zigmund AS, Snaith R P. The hospital anxiety and depression scale. Acta Psyciatr Scand 1983;67:361–70.
- Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD and the Clinical Significance Consensus Meeting Group. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proceed 2007;82:1244–54.
- Bjorner JB, Kosinski M, Ware Jr JE. The feasibility of applying item response theory to measures of migraine impact: A re-analysis of three clinical studies. Qual Life Res 2003;12:887–902.
- Cella D, Wagner L, Cashy J, Hensing TA, Yount S, Lilenbaum RC. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy. J Natl Canc Inst Monogr 2007;37:53–60
- Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials– guidelines and a checklist for protocol writers: The UK Medical Research Council experience. MRC Cancer Trials Office. Eur J Canc 1997;33:20–8.
- Haes de J, Curran D, Young T, Bottomley A, Flechtner H, Aaronson N, . for the EORTC Quality of Life Study Group. Quality of life evaluation in oncological clinical trials– the EORTC model. Eur J Canc 2000;36:821–5.
- Sprangers MAG, Moinpour C, Moynihan T, Patrick D, Revicki D, and the Clinical Significance Consensus Meeting Group. Assessing meaningful change in quality of life over time: A users’ guide for clinicians. Mayo Clin Proceed 2002;77:561–71.
- Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'haese S, . Beyond the development of health-related quality of life (HRQOL) measures. A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision-making? J Clin Oncol 2003;21:3502–11.
- Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the health-related quality of life reporting in clinical cancer trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol 2007;18:775–81.
- Bottomley A, Jones D, Claassens L. Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 2009;45:347–53.
- Idler EL, Benyamini Y. Self-rated health and mortality: A review of 27 community studies. J Health Soc Behav 1997;38:21–37.
- Singh JA, Nelson DB, Fink HA, Nichol KL. Health-related quality of life predicts future health-care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study. Semin Arthritis Rheum 2005;34:755–65.
- Cunningham WE, Crystal S, Bozzette S, Hays RD. The association of health-related quality of life with survival among persons with HIV infection in the United States. J Gen Int Med 2005;20:21–7.
- Mapes DL, Lopes AA, Satayathum S, Mccullough KP, Goodkin DA, Locatelli F, . Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003;64:339–49.
- Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008;26:355–63.
- Benyamini Y. Self-ratings of health and longevity: A health psychologist's viewpoint on epidemiological findings. Eur Health Psychol 2008;10:10–13.
- Pressman SD, Cohen S. Does positive affect influence health? Psych Bull 2005;131:925–71.
- Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993;2:221–6.
- Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988.
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Contr Clin Trials 1989;10:407–15.
- Junniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidem 1994;47:81–7
- Sloan JA, Cella D, Frost M, Guyatt G, Sprangers MAG, Symonds T and the Clinical Significance Consensus Meeting Group. Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceed 2002;77:367–70.
- Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life. The remarkable universality of half a standard deviation. Med Care 2003;41:582–92.
- Beaton DE. Simple as possible? Or too simple? Possible limits to the universality of the one half standard deviation. Med Care 2003;41:593–6.
- Wright JG. Interpreting health-related quality of life scores. The simple rule of seven may not be so simple. Med Care 2003;41:597–8.
- Farivar SS, Liu H, Hays RD. Half standard deviation estimates of the minimally important difference in HRQL scores? Exp Rev Pharmacoecon Outcom Res 2004;4:89–97.
- Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidem 2008;61:102–9.
- Norman GR, Wyrwich KW, Patrick DW. The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res 2007;16:815–22.
- Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidem 2003;56:395–407.
- Schwartz CE, Sprangers MAG. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999;48:1531–48.
- Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality-of-life research: A theoretical model. Soc Sci Med 1999;48:1507–15.
- Bernhard J, Hürny C, Maibach R, Herrmann R, Laffer U. For the Swiss Group for Clinical Cancer Research (SAKK). Quality-of-life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Ann Oncol 1999;10:775–82.
- Sprangers MAG, Schwartz CE. The challenge of response shift for quality-of-life based clinical oncology research. Ann Oncol 1999;10:747–9.
- Barclay-Goddard R, Epstein JD, Mayo NE. Response shift: A brief overview and proposed research priorities. Qual Life Res 2009;18:335–46.
- Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, . Revealing response shift in longitudinal research on fatigue–the use of the thentest approach. Acta Oncol 1999;38:709–18.
- Andrykowski MA, Donovan KA, Jacobsen PB. Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Sympt Manage 2009;37:341–51.
- Broberger E, Sprangers MAG, Tishelman C. Do internal standards of quality of life change in lung cancer patients? Nurs Res 2006;55:274–82.
- Jansen SJT, Stiggelbout AM, Nooij MA, Noordijk EM, Kievit J. Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res 2000;9:603–15.
- Korfage IJ, de Koning HJ, Essink-Bot ML. Response shift due to diagnosis and primary treatment of localized prostate cancer: A then-test and a vignette study. Qual Life Res 2007;16:1627–34.
- Rees J, Waldron D, O’Boyle C, Ewings P, MacDonagh R. The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcom 2005;3:1–8.
- Visser MRM, Oort FJ, Sprangers MAG. Methods to detect response shift in quality of life data: A convergent validity study. Qual Life Res 2005;14:629–39.
- Schwartz ES, Bode R, Repucci N, Becker J, Sprangers MAG, Fayers PM. The clinical significance of adaptation to changing health: A meta-analysis of response shift. Qual Life Res 2006;15:1533–50.
- Lykken D, Tellegen A. Happiness is a stochastic phenomenon. Psychol Sci 1996;7:186–9.
- Stubbe JH, Posthuma D, Boomsma DI, De Geus EJ. Heritability of life satisfaction in adults: A twin-family study. Psychol Med 2005;35:1581–8.
- Nes RB, Røysamb E, Tambs K, Harris JR, ReichbornKjennerud T. Subjective well-being: Genetic and environmental contributions to stability and change. Psychol Med 2006;36:1033–42.
- Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiat 2000;157:1552–62.
- Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiat 2001;158:1568–78.
- Leinonen R, Kaprio J, Jylhä M, Tolvanen A, Koskenvuo M, Heikkinen E, . Genetic influences underlying self-rated health in older female twins. J Am Geriatr Soc 2005;53:1002–7.
- Svedberg P, Gatz M, Lichtenstein P, Sandin S, Pedersen NL. Self-rated health in a longitudinal perspective: A 9-year follow-up twin study. J Gerontol B Psychol Sci Soc Sci 2005;60:S331–S340.
- Svedberg P, Bardage C, Sandin S, Pedersen NL. A prospective study of health, life-style and psychosocial predictors of self-rated health. Eur J Epidemiol 2006;21:767–76.
- Romeis JC, Heath AC, Xian H, Eisen SA, Scherrer JF, Pedersen NL, . Heritability of SF-36 among middle-age, middle-class, male-male twins. Med Care 2005;43:1147–54.
- Bao A, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res Rev 2008;57:531–53.
- Sprangers MAG, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, . The establishment of the GENEQOL Consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Gen 2009;12:301–11.
- Sloan J, Zhao X. Genetics and quality of life. Curr Probl Cancer 2006;30:255–60.
- Yang P, Mandrekar SJ, Hillman SH, Allen Ziegler KL, Sun Z, Wampfler JA, . Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study. J Thorac Oncol 2009;4:479–85.
- Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269–76.
- De Gargino JP. Children's health and the environment: A global perspective. Geneva: World Health Organization; 2004.
- Howell RT, Kern ML, Lyubomirsky S. Health benefits: Meta-analytically determining the impact of well-being on objective health outcomes. Health Psych Rev 2007;1:83–136.
- Fowler JH, Christakis NA. Dynamic spread of happiness in a large social network: Longitudinal analysis over 20 years in the Framingham Heart Study. Br Med J 2008;337:a2338 (doi:10.1136/bmj.a2338).